A phase II Study of obexelimab in patients with relapsing multiple sclerosis

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2024
This article has no abstract
Epistemonikos ID: 9fb07c92daca0ccc137f5cb862ce45d300ab6fb5
First added on: Jan 17, 2025